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Abstract 
Introduction: High calorie diet is becoming the most important health problem in most 
developed western societies. Diets with high caloric contents such as high fructose intake are 
associated with increasing risk of type two diabetes (T2D) and insulin resistance (IR). 
However, large differences have been seen in the dose and duration of fructose consumption 
to induction of T2D. Interest to develop animal models, in which IR is induced by feeding a 
high caloric diet, is the main aim of this study. 
Materials and methods: Male Sprague-Dawley rats were randomly sorted into three groups, 
control and fructose-treated (10 and 20 %) animals. After 6 and 14 weeks, fluid intake, body 
weight, intraperitoneal glucose tolerance test, metabolic parameters (glucose, insulin, 
triglyceride, cholesterol, uric acid) and homeostasis model assessment of insulin resistance 
were checked. 
Results: There was no difference between the body weight of the fructose-treated (10 and 20 
%) and control groups during the experiment. Fluid intake in fructose-treated ones (10 and 20 
%) was significantly higher than the control group from third week to the end of experiment. 
Intraperitoneal glucose tolerance test was the same for all groups in either sixth or fourteenth 
weeks. Fasting plasma insulin, triglyceride, uric acid and homeostasis model assessment of 
insulin resistance and glucose tests showed significant enhancement in fructose-treated rats 
(20%) only after 14 weeks. 
Conclusion: Consumption of high fructose solution (20%) for 14 weeks could induce IR, but 
using of low dose of fructose (10% for 6 or 14 weeks) didn’t develop it. 
Keywords: Fructose, Insulin resistance, Type 2 diabetes, Sprague-Dawley rat 
Introduction 
Type-2 diabetes (T2D) is known as a 
serious socio-economic problem (1). 
Epidemiological studies have shown that 
more than 100 million people in the world 
suffered from T2D. This type of diabetes 
is a complex and heterogeneous disorder is 
distinguished by a progressive decline in 
insulin action or defect in insulin signal 
transduction (1, 2). In this case, the tissues 
can’t utilize glucose normally, that is 
associated with serum triglycerides 
enhancement, serum HDL reduction and 
sometimes LDL enhancement (3). 
Appropriate animal models are required to 
understanding of the pathogenesis and 
complications of T2D  Rn  na  (4). Insulin 
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resistance can be induced by injection of 
some chemicals like streptozotocin (STZ) 
(low dose of STZ in combination with 
high fat or high calorie diet), using 
transgenic animals, and special diet 
consumption (high fat or high calorie diet). 
These chemicals are commonly used, but 
they are inefficient to induction a close 
reality model of T2D. In fact, a real insulin 
resistance does not induce by these 
methods, and the insulin deficiency and 
hyperglycaemia are inducing primarily by 
direct adverse action of the chemicals on 
beta cells (4). 
Currently, a large number of genetically 
modified animal models, such as 
transgenic animals, or tissue-specific 
knock-out mice, hereditary ob. /ob. mice 
and Sprague Dawley or Wistar rat models 
have been developed for the study of 
diabetes. These models create a more 
appropriate pathogenesis model for the 
disease, but great varieties of such models 
are required to study the effect of T2D on 
different organs. However, these models 
are very expensive, difficult to maintain, 
and are hardly found among research labs, 
particularly in developing countries (5, 6). 
Fructose with a chemical formula 
(C6H12O6) similar to glucose which can be 
found in many fruits, vegetables and 
beverages. Fructose intake in excess can 
induce moderate obesity and have several 
deleterious metabolic effects, including 
hyper-triglyceridemia and hyper-
insulinaemia (7). 
On the base of these evidences, some 
researchers attempted to induce a model of 
T2D using fructose. Large differences 
have been seen in the result of fructose 
consumption to induction of T2D. Collino 
M et al. (2010) reported that a high 
fructose solution (10%) for 15 weeks 
could induce insulin resistance (IR) (8); 
Also, it has been shown that the same 
concentration of fructose for 9weeks 
induced T2D in female rats (9). However, 
De Moura and his colleagues (2009) have 
shown that consumption of a high fructose 
solution in Wistar rats, for 8 weeks, did 
not change metabolic parameters and 
could not make T2D (7). 
The primary objective of this research was 
to develop a suitable, non-genetic model of 
T2D in Sprague-Dawley rat. We proposed 
that this model may mimic symptoms and 
clinical pathogenesis which is seen in 
people with T2D. In the present study; we 
examined the effect of two different doses 
of oral fructose (10% and 20%), during 6 
and 14 weeks in male Sprague-Dawley 
rats. 
 
Materials and methods 
Animals: Male Sprague-Dawley rats (100-
120g, 40 days age) were prepared from the 
animal lab of Shiraz University of Medical 
Sciences. All experiments (Experimental 
study, random sampling) done (May, 
2013) in accordance with the Animal 
Ethics Committee (approval license No: 
90-5702) of the Shiraz University of 
Medical Sciences guidelines. Animals 
were weighed and grouped randomly into 
three groups (n = 8). They were kept at 
standard temperature (22-25°C), 12h light–
dark cycles, and free access to standard 
chow in all groups. They also had access 
to tap water and fructose in drinking water 
(10 or 20%) ad libitum in control and 
fructose-treated groups, respectively for 14 
weeks. 
Fluid intake and body weight: Changes 
in fluid intake and body weight were 
weekly assessed. Figure 1 shows the mean 
body weight during the 14 weeks. 
Intraperitoneal glucose tolerance test 
(IGTT): After 6 or 14 weeks, animals 
were sustained while fasting for 15h and 
then were anesthetized with a mixture of 
ketamine and xylazine (70 and 10 mg/kg 
i.p., respectively). An unchallenged 
sample checked at time of zero. Thirty, 60, 
90 and 120 minutes following injection of 
2gr/kg glucose intraperitoneally, blood 
samples were checked by glucose meter 
(ACCU-CHEK Active, Germany) to 
determine the glucose concentration (10, 
11). 
Original article                                                              J Bas Res Med Sci2014; 1(4):42-50 . 
 
44 
 
Metabolic parameters analysis: Before 
easuring the glucose tolerance test, a 
sample of blood (0.5 ml) is taken from the 
tail for analyzing the metabolic parameters 
(fasting glucose, insulin, 
triglyceride,cholesterol and uric acid). Non 
fasting glucose and homeostasis model 
assessment of insulin resistance (HOMA-
IR index) were also checked. 
Plasma glucose level was assayed by 
glucoseoxidase–peroxidase method (Pars 
Azmun kit, Iran). Triglyceride (TG), 
cholesterol and uric acid were assayed by 
enzymatic colorimetric end point methods 
(Pars Azmun kit, Iran). However; Plasma 
insulin was analyzed by using an ultra-
sensitive rat insulin ELISA kit (Mercodia, 
Sweden). Fasting serum insulin and fasting 
blood glucose concentrations was 
measured and the homeostasis model 
assessment-estimated insulin resistance 
(HOMA-IR index) calculated according to 
the following formula (11): HOMA-IR = 
[fasting glucose (mM) × fasting insulin 
(mU/mL)] / 22.5 
All data are presented as mean ± SEM. To 
determine the significant 
differencebetween test and control groups, 
the variance (ANOVA) was analyzed with 
SPSS11.5 statistical software. Significant 
differences between the two groups were 
assessed by Turkey’s test (P <0.05 was 
considered statistically significant). 
Figures are being drawn using Excel 
software.  
Results 
Body weight and fluid intake: Body 
weight did not show any significant 
difference between fructose-treated (10 
and 20 %) and control groups in each 
weeks (Figure 1). But in some weeks, fluid 
intake in fructose-treated 10 % and 20 % 
was significantly higher than the control 
group (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Mean body weight gain during 14 weeks in fructose –treated and control 
rats. DRtR Rre shown Rs the meRn ± SEM (n= 8 RnimRls). 
Original article                                                              J Bas Res Med Sci2014; 1(4):42-50 . 
 
45 
 
Intraperitoneal glucose tolerance test: 
This parameter showed no significant 
difference between fructose-treated and 
control groups after 6 or 14 weeks (Figure 
2).
 
 
 
 
 
 
 
 
 
Metabolic parameters: Fasting plasma 
insulin (P <0.001), triglyceride (P <0.05), 
cholesterol (P <0.05), uric acid (P <0.01), 
HOMA-IR index (P <0.001) and non-
fasting glucose (P <0.01) increased 
significantly in 20% fructose-treated 
compare to other groups only after 14 
weeks. Metabolic parameters (in except of 
cholesterol) was not significantly different 
in control and 10% fructose treatment 
animals. Fasting glucose was similar in all 
groups (Table 1, Figures 3 and 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Intraperitoneal glucose tolerance test (IGTT) in fructose drinking and 
control rats after 14 weeks. 
Figure 3. Fasting insulin concentration in fructose drinking compared to the control 
animals. (†significRnt  ifference (p < 0.001) compared to control group).   
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Table 1. Metabolic parameters in fructose treated and control rats after 6 and 14 weeks. 
 
 
 
Metabolic 
staterarap 
Groups 
6 weeks treatments 14 weeks treatments 
Fructose 
(10%) 
Fructose 
(20%) 
Control Fructose 
(10%) 
Fructose 
(20%) 
Control 
Fasting glucose 
(mg/dl) 
134±4 140±16 131±6 142±8 134±7 132±5 
Non-fasting glucose 
(mg/dl) 
266±30 280±43 237±18 258±17 340±28 
**
 249±31 
Uric acid  
(mg/dl) 
1.08±.05 1.13±.16 0.99±.11 0.99±.07 2.93±.5 
**
 1.08±.05 
Triglyceride 
(mg/dl) 
66±10 83±15 70±8 71±9 134±23 
*
 86±6 
Cholesterol  
(mg/dl) 
72±4 108±17 
*
 69±6 109±11
 *
 126±14 
*
 83±9 
*, ** represent p < 0.05 and p < 0.01 in comparison with control group, respectively. 
Discussion 
T2D is a multi-factorial disorder, usually 
associated with a set of pathologic 
symptoms such as obesity, 
hypertriglyceridemia, glucose intolerance 
and insulin resistance (IR) (3). To 
understanding the mechanisms which 
involves in pathological symptoms of T2D 
development; it must be made an 
appropriate animal model. Many attempts 
were done in this relation. However, the 
great controversy was seen in dose and 
duration of fructose intake in induction of 
T2D. As De Moura and his colleagues 
(2009) have shown that 6 or 8 weeks 
consumption of a high fructose solution 
didn’t change metabolic parameters and 
could not induce T2D in Wistar or 
Sprague-Dawley rats (7). However; beta 
Figure 4. Homeostasis model assessment of insulin resistance (HOMA-IR) in 
fructose  rinking compRre  to control RnimRls († significRnt  ifference (p < 0.001). 
.compared to control group).             
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cells impairment and mortality rate was 
high when some drugs were used such as 
STZ (in low dose) in combination to 
fructose for T2D induction (4). Genetically 
modified animal models, also are too 
expensive, difficult to maintain and are 
hardly found among research labs, 
particularly in undeveloping countries (5, 
6). For these reasons, the primary 
objective of this research was to develop 
an alternative non-genetic model in 
Sprague- Dawley rat for T2D, which 
mimic symptoms and clinical pathogenesis 
seen in people with IR, and on the other 
hands, induce of T2D as easily. In the 
present study, was tested the effect of two 
different dose of fructose (10% and 20%) 
during 6 and 14 weeks in male Sprague-
Dawley rats on T2D induction. 
According to our data, chronic 
consumption (14 weeks) of fructose 
solution (20%) changed the metabolic 
parameters and induced T2D. The same 
results were achieved about female Wistar 
rats by Zakula Z et al. (9). 
The mechanism underlying the effects of 
fructose is the hepatic intermediary 
metabolism. Fructose bypasses the 
phosphofructokinase regulatory pathway 
and enters the glycolysis or 
gluconeogenesis cycles at the triose 
phosphate step which in increases hepatic 
triglyceride production (12). Hyper-
triglyceridemia in fructose-treated animals 
has been proposed caused by either 
VLDL-TG enhancement due to an 
increased hepatic secretion of them or a 
decreased elimination of TG-rich 
lipoproteins from the circulation (13). 
Plasma triglycerides and cholesterol 
enhancement are the major factors of IR 
induction. Entrance ability of glucose to 
the cells and its oxidation was inhibited by 
fatty acids through the glucose transporters 
activity impairment and change of the 
enzymatic activity of glycogen synthesis. 
Thus, was occurred prolonged 
hyperglycemia and insulin action 
impairment (14). A new hypothesis 
provided by recent findings show that a 
high fructose concentration causes uric 
acid enhancement, which inhibits nitric 
oxide (NO  ) availability. It has been 
showed that insulin act through the NO for 
glucose uptake stimulation, and it can be 
assumed that fructose-induced 
hyperuricemia may have a pathogenic role 
in insulin resistance induction and 
metabolic syndrome development (15). 
Other studies have shown that fructose can 
induce uric acid generation, and thereby 
develops mitochondrial oxidative stress 
which stimulates fat accumulation (16). 
Some research had reported a significant 
enhancement in fasting plasma glucose 
level after fructose consumption (17) and 
the other did not show any significant 
changes (13). But, in contradiction with 
some previous findings (17-19), we found 
that, fructose intake for 14 weeks did not 
make impairment in fasting blood glucose. 
One possible reason for this is, in our 
model, pancreas is intact (did not use of 
chemical agents in combination to fructose 
intake to destruction of beta cells) and has 
appropriate response to blood glucose 
fluctuations. So we suppose that insulin 
enhancement keep the fasting blood 
glucose in normal level but response to 
insulin is lower than the normal so that 
non-fasting glucose increase with fructose 
consumption. Hyper-insulinemia 
compensate low insulin sensitivity for 
maintain of normal glucose homeostasis 
(15). Glucose-regulation did not alter in 
mice which was drinking 15% fructose 
solution for 16 weeks and also Wistar rats 
used high fructose solution (10%) for 8 
weeks (7, 20-21). Axelsen et al. (2009) 
achieved similar results with male 
Sprague-Dawley rats in which animals 
were fed high cholesterol-fructose diet for 
15 weeks (22). The animals’ weight and 
fluid intake were measured weekly. Fluid 
intake in fructose-treated rats was greater 
than control group, from 3th weeks of 
treatment to the end of experiment. 
Animal’s growth was normally, but their 
body weight did not show any significant 
difference in experimental groups in each 
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week. The results of the present study are 
similar to those of Takatori et al., Van der 
et al. and Zamamiet al. (19, 23-24). 
However, Stranahanet al. and Brito et al. 
showed high fructose diet promotes weight 
gain in rodents (17, 25). High fructose 
consumption may results in an increase in 
body weight through the positive energy 
balance. Obesity due to positive energy 
balance associate with a high 
concentration of free fatty acids, which 
may diminish insulin sensitivity and an 
increase in blood glucose level (3). 
However; in our study, any difference was 
observed in body weight parameter 
between fructose-treated and control 
animals, proposing that obesity is not a 
major contributor to induction of T2D. 
Amount of fructose intake was also 
measured in some studies, and various 
results were reported (4, 23). The reasons 
for these differences might be the different 
route of fructose administration as some 
studies used of fructose with combination 
to food. Another reason may be the 
difference of experimental rodent´s species 
that might make different susceptibility to 
fructose treatment. 
This model may mimic symptoms and 
clinical pathogenesis are seen in people 
with T2D which can be developed as an 
easier method (low cost and simple 
method) with compared to several existing 
animal models of T2D. 
Conclusion 
Results of this research show that using of 
low dose of fructose (10% for 6 or 14 
weeks) didn’t develop T2D, but high 
fructose solution (20%) intake only in long 
term (14 weeks) could make it in male 
Sprague-Dawley rats. This animal model 
can be used to studies in which require to 
an animal model of T2D with IR. 
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